Company Profile

Helix BioMedix (AKA: Helix International Corporation)
Profile last edited on: 12/14/2015      CAGE: 7F5R2      UEI: ENXUCR1BNWL4

Business Identifier: Bioactive-peptides
Year Founded
1985
First Award
1986
Latest Award
1988
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

22118 20th Avenue South East Suite 204
Bothell, WA 98021
   (425) 402-8400
   N/A
   www.helixbiomedix.com
Location: Single
Congr. District: 01
County: Snohomish

Public Profile

Formerly doing business as Helix Interational Corporation located in BatonRouge LA, Helix BioMedix, Inc. is a late-stage biotechnology company that has a portfolio of issued patents that covers six distinct classes of peptides, covering over 1 million unique peptide sequences. The company's mission is to become the industry leader in developing and commercializing small proteins known as bioactive peptides. The antimicrobial and wound healing properties of these peptides qualify them for inclusion in a wide range of both pharmaceutical and consumer products. The company is currently focused on the development of selected peptides as topical anti-infectives and in wound healing. Non-pharmaceutical applications being pursued by Helix BioMedix include adjuvants for cosmetics/cosmeceuticals, personal care, plant health, animal health and wide-spectrum biocides. The company offers small proteins known as bioactive peptides. Its uses include anti-aging skin care, acne treatment, wound healing, and treatment of athlete's foot and other fungal infections of the skin and hair, including the management of various dermatoses. Helix BioMedix also develops peptides in various therapeutic and industrial product categories, such as oral care, biocides, and animal health.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
Yes
Public/Private
Publicly Traded
Stock Info
OTC : HXBM
IP Holdings
25-49

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
1988 1 NIH $50,000
Project Title: In vitro culture of preimplantation embryos
1988 1 NIH $50,000
Project Title: Rapid processing of bioactive peptides and proteins
1987 1 NIH $50,000
Project Title: Applied Embryology Techniques in Nonhuman Primates
1986 1 NIH $50,000
Project Title: Techniques for gene transfer in fish

Key People / Management

  R Stephen Beatty -- President

  Robin L Carmichael -- President and COO

  Timothy Falla -- CSO

  Alissar Nehme

  James K Smith

  Steven A Voelkel

  Lijuan Zhang -- Senior Director of R & D Innovation

Company News

There are no news available.